FOSRENOL: Focused on the Challenging Needs of Patients With ESRD

  • Provided effective phosphate reduction in studies lasting up to 3 years1-3
  • Developed with dosing options4
  • Over 5200 patients studied in completed clinical trials4
  • FOSRENOL On Track™ Support Program reinforces your efforts with materials that may help patients manage their condition

Learn More

Flexible Dosing Options

Send to a Colleague


No personal information (including e-mail addresses) will be collected from this feature.